This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-A Ventis Deutschland Gmbh. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Wendeline Frick: Innovator in Antidiabetic Medicaments
Introduction
Wendeline Frick is a notable inventor based in Munich, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of antidiabetic compounds. Her innovative work has led to the creation of a patent that addresses important health issues.
Latest Patents
Wendeline Frick holds a patent for "Fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof." This invention relates to substituted fluoroglycoside derivatives of pyrazoles, which are defined in detail within the patent specification. The patent also covers the physiologically compatible salts of these compounds, a method for their production, and their application as antidiabetics. She has 1 patent to her name.
Career Highlights
Wendeline Frick is currently employed at Sanofi-Aventis Deutschland GmbH, a leading global healthcare company. Her role involves research and development in the pharmaceutical sector, where she focuses on creating innovative solutions for diabetes management.
Collaborations
Throughout her career, Wendeline has collaborated with esteemed colleagues, including Harm Brummerhop and Heiner Glombik. These partnerships have enhanced her research and contributed to the advancement of her projects.
Conclusion
Wendeline Frick's contributions to the field of antidiabetic medicaments highlight her innovative spirit and dedication to improving health outcomes. Her work continues to inspire advancements in medicinal chemistry.